Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. and covers a range of therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators and vaccine adjuvants. SafeCoat Medical Inc.'s technology incorporates self-assembling biocompatible polymers combined with conjugated antimicrobial peptides.


CSE:ASEP - Post by User

Post by StockHawk1on Dec 29, 2021 3:20pm
103 Views
Post# 34268648

Huge demand for ASEP's sepsis diagnostic technology

Huge demand for ASEP's sepsis diagnostic technology

Asep Medical Holdings Inc ( $ASEP.C ) is a biotech company that is in the clinical trial phases of testing its sepsis detection technology. 


In 2017 alone sepsis occurred in 49 MILLION people. Currently, antibiotics are the go-to treatment for sepsis but for 23% of these patients, antibiotics fail. This contributes to the 11 million deaths caused by sepsis yearly.


$ASEP's tech includes a novel diagnostic tool that detects the dysfunctional immune response that underlies the most severe forms of sepsis. This tech will facilitate early sepsis detection which will allow doctors to make better informed life-saving decisions which will add to the efficacy of antibiotics. 


The infection rate and death toll alone illustrates the demand for $ASEP's sepsis tech.


Clinical testing is already underway for the sepsis detection tech and the company intends to file for regulatory approval within the next 6-9 months which could be a huge catalyst for the company. 


Right now $ASEP is trading at $0.50 (stable today)


https://asepmedical.com/technologies/diagnostic/

 
<< Previous
Bullboard Posts
Next >>